With technology advancing, more possibilities appear for treating conditions that had no treatment before, or to treat conditions more efficiently. Examples are the mRNA vaccines that played an important role in controlling the Covid pandemic and the developments around stem cell research for the potential treatment of a wide variety of devastating diseases. In this lecture, an overview of the developments and potential of both ‘novel’ tools in the biopharmaceutical field that are being worked on at our member Brightlands Campus. The same tools that contribute towards successful therapy commercialization and scaled-up manufacturing processes for the production of life changing medicines.
- Dit evenement is voorbij.
Brightlands Science Lecture on the Medicines of Tomorrow
22 februari @ 12:00 - 14:00
Insights within the development of cutting edge novel therapeutics
Program
12.00-12.05h
Moderator Tillmann Schnierda – Director mRNA R&D and operations
12.05-12.20h How Preclinical Decisions Can Accelerate (or Delay) Your Entry into Phase I Clinical Trials
Kickstart lecture by Ilaria Pettinati, PhD, Group Lead Process Development mRNA at Lonza on “mRNA Process Development
12.20-13.00h Development of a pharmaceutical manufacturing process for iPSC Therapies
Science Lecture by Darrin Kuijstermans, Ph.D, M.Sc.(Eng), DBA, Director, Site Management, Head of Process Development at Lonza
13.00-14.00h
Q&A and Drinks